A PHASE 1, OPEN-LABEL, NON-RANDOMIZED, DOSE ESCALATING SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF TAS-119 IN PATIENTS WITH ADVANCED SOLID TUMORS
2014-001272-63TUMORES SOLIDOS AVANZADOSFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR